My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 111

    1.

    Tumor biology and cancer therapy - an evolving relationship.

    Seufferlein T, Ahn J, Krndija D, Lother U, Adler G, von Wichert G.

    Cell Commun Signal. 2009 Aug 13;7:19.PMID: 19678929 [PubMed - in process]Related articlesFree article

    2.

    Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.

    Adams R, Meade A, Wasan H, Griffiths G, Maughan T.

    Expert Rev Anticancer Ther. 2008 Aug;8(8):1237-45. Review.PMID: 18699762 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pancreatic cancer: molecular pathogenesis and new therapeutic targets.

    Wong HH, Lemoine NR.

    Nat Rev Gastroenterol Hepatol. 2009 Jul;6(7):412-22. Epub 2009 Jun 9. Review.PMID: 19506583 [PubMed - indexed for MEDLINE]Related articles

    4.

    A new era of cancer therapy: cancer cell targeted therapies are coming of age.

    Voltz E, Gronemeyer H.

    Int J Biochem Cell Biol. 2008;40(1):1-8. Epub 2007 Sep 21. Review.PMID: 17951100 [PubMed - indexed for MEDLINE]Related articles

    5.

    Novel agents for the treatment of adenocarcinoma of the pancreas.

    Mackenzie RP, McCollum AD.

    Expert Rev Anticancer Ther. 2009 Oct;9(10):1473-85. Review.PMID: 19828009 [PubMed - indexed for MEDLINE]Related articles

    6.

    Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy.

    Hsu JY, Wakelee HA.

    BioDrugs. 2009;23(5):289-304. doi: 10.2165/11317600-000000000-00000. Review.PMID: 19754219 [PubMed - indexed for MEDLINE]Related articles

    7.

    Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer.

    Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J, Bardelli A.

    J Natl Cancer Inst. 2009 Oct 7;101(19):1308-24. Epub 2009 Sep 8. Review.PMID: 19738166 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Erlotinib in the treatment of advanced pancreatic cancer.

    Kelley RK, Ko AH.

    Biologics. 2008 Mar;2(1):83-95.PMID: 19707431 [PubMed - in process]Related articlesFree article

    9.

    Mucosal injury from targeted anti-cancer therapy.

    Keefe DM, Gibson RJ.

    Support Care Cancer. 2007 May;15(5):483-90. Epub 2006 Nov 14. Review.PMID: 17103195 [PubMed - indexed for MEDLINE]Related articles

    10.

    The long road to colorectal cancer therapy: Searching for the right signals.

    Hollande F, Pannequin J, Joubert D.

    Drug Resist Updat. 2010 Feb 21. [Epub ahead of print]PMID: 20176501 [PubMed - as supplied by publisher]Related articles

    11.

    Improving disease control in advanced colorectal cancer: Panitumumab and cetuximab.

    Rodríguez J, Viúdez A, Ponz-Sarvisé M, Gil-Aldea I, Chopitea A, García-Foncillas J, Gil-Bazo I.

    Crit Rev Oncol Hematol. 2009 Aug 21. [Epub ahead of print]PMID: 19700342 [PubMed - as supplied by publisher]Related articles

    12.

    Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.

    Moreno-Aspitia A, Perez EA.

    Clin Ther. 2009 Aug;31(8):1619-40. Review.PMID: 19808124 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Molecular therapeutics in patients with cancer unresponsive to conventional treatments]

    Valdespino-Gómez VM, Valdespino-Castillo VE.

    Gac Med Mex. 2008 Jul-Aug;144(4):333-44. Review. Spanish. PMID: 18942268 [PubMed - indexed for MEDLINE]Related articles

    14.

    Pediatric developmental therapies: interesting new drugs now in early-stage clinical trials.

    Macy ME, Sawczyn KK, Garrington TP, Graham DK, Gore L.

    Curr Oncol Rep. 2008 Nov;10(6):477-90. Review.PMID: 18928662 [PubMed - indexed for MEDLINE]Related articles

    15.

    Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies.

    Roukos DH.

    Expert Rev Mol Diagn. 2008 Jan;8(1):29-39. Review.PMID: 18088228 [PubMed - indexed for MEDLINE]Related articles

    16.
    17.

    [Evidence based of chemoradiotherapy in cervix carcinoma]

    Joly-Lobbedez F.

    Cancer Radiother. 2009 Oct;13(6-7):503-6. Epub 2009 Aug 19. French. PMID: 19695934 [PubMed - indexed for MEDLINE]Related articles

    18.

    Glioblastoma Multiforme Oncogenomics and Signaling Pathways.

    Kanu OO, Hughes B, Di C, Lin N, Fu J, Bigner DD, Yan H, Adamson C.

    Clin Med Oncol. 2009 Apr 8;3:39-52.PMID: 19777070 [PubMed]Related articlesFree article

    19.

    Emerging therapies for metastatic colorectal cancer: focus on EGFR and VEGF inhibition.

    Venook AP.

    J Natl Compr Canc Netw. 2004 Sep;2 Suppl 2:S74-84. Review.PMID: 19780248 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Integrated therapy and research progress in molecular therapy for intracranial tumor]

    Cho WC.

    Nan Fang Yi Ke Da Xue Xue Bao. 2007 Jul;27(7):1047-51. Chinese. PMID: 17666347 [PubMed - in process]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk